Thompson Siegel & Walmsley’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-2,700
Closed -$83K – 787
2020
Q4
$83K Sell
2,700
-530
-16% -$12.6K ﹤0.01% 404
2020
Q3
$60K Hold
3,230
– – ﹤0.01% 414
2020
Q2
$45K Sell
3,230
-492
-13% -$6.66K ﹤0.01% 443
2020
Q1
$34K Buy
3,722
+568
+18% +$8.52K ﹤0.01% 433
2019
Q4
$55K Hold
3,154
– – ﹤0.01% 480
2019
Q3
$48K Hold
3,154
– – ﹤0.01% 507
2019
Q2
$60K Buy
3,154
+1,179
+60% +$20.1K ﹤0.01% 487
2019
Q1
$0 Buy
+1,975
New +$36.1K ﹤0.01% 745

Other funds holding VCEL

Thompson Siegel & Walmsley's VCEL Position: Q1 2021 in Review

Thompson Siegel & Walmsley sold out of Vericel Corp (VCEL) in Q1 2021, closing a stake of 2,700 shares — an estimated $83K sold.

Thompson Siegel & Walmsley first reported a position in VCEL in Q1 2019 and held it in 8 quarters. The position peaked at $83K in Q4 2020. 205 funds tracked by Wall St. Rank hold VCEL as of Q1 2021.

  • Thompson Siegel & Walmsley reported no remaining Vericel Corp position as of Q1 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 2,700 Vericel Corp shares in Q1 2021, an estimated $83K.
  • Thompson Siegel & Walmsley first reported a position in Vericel Corp in Q1 2019 and held it in 8 quarters.
  • Thompson Siegel & Walmsley's Vericel Corp position peaked at $83K in Q4 2020.
  • 205 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2021, filed 7 May 2021.